Related Experiment Video
Updated: May 24, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
The high-risk newborns
1Neonatology and Neonatal Intensive Care Unit, BBM Foundation-S Gerardo Hospital, Monza, taly. p.tagliabue@hsgerardo.org
Summary
High-risk newborns, including those with hypoxic-ischemic encephalopathy and very preterm infants, require specialized care. Implementing targeted follow-up programs is crucial for monitoring their long-term growth and development.
Area of Science:
- Neonatology
- Pediatric Intensive Care
Background:
- High-risk newborns are a significant patient population in neonatal intensive care units (NICUs).
- These infants face a high likelihood of severe acute disease or adverse outcomes.
- Specific populations, such as term newborns with hypoxic-ischemic encephalopathy and very preterm newborns, demand particular attention.
Purpose of the Study:
- To emphasize the critical need for specialized surveillance of high-risk newborns.
- To advocate for structured follow-up programs tailored to the unique needs of these infants.
Main Methods:
- This abstract focuses on defining high-risk newborns and outlining care considerations.
- It highlights the necessity of ongoing monitoring for specific patient groups.
Main Results:
- High-risk newborns constitute the majority of NICU admissions.
- Term newborns with hypoxic-ischemic encephalopathy and very preterm newborns require dedicated growth and developmental surveillance.
Conclusions:
- A systematic follow-up program is essential for managing high-risk newborns.
- Long-term monitoring is vital to ensure optimal outcomes for these vulnerable infants.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.